Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Shilpa Medicare LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:530549NSE Symbol: SHILPAMEDP/E(TTM):68.17
ISIN Demat:INE790G01031Div & Yield %:0.13EPS(TTM):5.54
Book Value(Rs):138.0799192Market Cap ( Cr.):7386.15Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 477.34309.79247.70356.95257.05805.97
Excise Duty0.000.000.000.000.000.00
Net Sales477.34309.79247.70356.95257.05805.97
Other Income 84.8589.12175.32170.50204.4936.79
Stock Adjustments -6.00-2.63-4.083.1810.2614.26
Total Income556.19396.28418.94530.63471.80857.02
EXPENDITURE :      
Raw Materials 114.5086.6278.1281.9669.37279.83
Power & Fuel Cost17.9618.7318.7017.4712.4235.31
Employee Cost 99.61103.64109.54110.5776.10149.28
Other Manufacturing Expenses 13.2415.3218.2822.7916.7135.94
Selling and Administration Expenses 101.4549.7460.03106.2255.9267.02
Miscellaneous Expenses 46.7217.2618.50-0.573.4312.50
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure393.49291.31303.17338.44233.95579.87
Operating Profit162.69104.96115.78192.18237.86277.15
Interest 6.6017.2620.839.056.074.33
Gross Profit156.0987.7094.95183.13231.79272.82
Depreciation48.8649.6146.5534.8222.2834.96
Profit Before Tax107.2338.0948.40148.31209.51237.86
Tax47.0811.29-8.374.8015.7839.09
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-9.64-0.13-0.432.539.345.05
Reported Net Profit69.8026.9457.19140.99184.39193.72
Extraordinary Items -25.03-6.93-15.868.2346.40-3.65
Adjusted Net Profit94.8333.8773.05132.76137.99197.37
Adjst. below Net Profit 0.000.000.000.000.000.00
P & L Balance brought forward1359.051332.111284.461152.44968.05794.97
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.009.558.970.0020.64
P & L Balance carried down1428.851359.051332.111284.461152.44968.05
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %100.000.000.00110.00110.00110.00
Earnings Per Share-Unit Curr7.143.106.5916.2422.6223.76
Earnings Per Share(Adj)-Unit Curr7.143.106.5916.2422.6223.76
Book Value-Unit Curr276.16246.85243.96237.97200.89178.27